74 results Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations. Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels. Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors. Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin. Stibbe represents the bankruptcy trustees of Amsterdam hospital MC Slotervaart in dispute with the City of Amsterdam Stibbe represented the bankruptcy trustees of the Amsterdam hospital MC Slotervaart in proceedings against the City of Amsterdam, centred on the City’s demand that the bankruptcy trustees investigate whether there were any irregularities prior to the ban Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector. Stibbe advises Aedifica Stibbe advised Aedifica on the acquisition of a healthcare residence for the elderly in Franeker (Friesland). Dutch national police service liable for unlawful granting of firearms permit In a recent decision (ECLI:NL:HR:2019:1409), the Supreme Court has decided that the Dutch national police force is liable for damage suffered by victims of a shooting which took place in a shopping centre in 2011; an event that shocked the Netherlands. Stibbe advises Wright Medical Group Stibbe is advising Wright Medical Group on the offer from Stryker to acquire Wright Medical Group. Stibbe advises Aedifica Stibbe advised Aedifica on its secondary share listing on Euronext Amsterdam. Trading started on 7 November 2019. Clémence Jonckheere Junior Associate Brussels Stibbe advises Aedifica Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Lelystad and the acquisition and lease of a recently completed care residence in Zwolle. Breaking news from the CJEU: no SPCs for new therapeutic applications On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products. Stibbe advises leading pharmaceutical company Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients. Stibbe advises Canon Advising Canon in connection with their dispute with the State of the Netherlands on the procurement of framework contracts. Case won up to and including the Supreme Court. Stibbe advises Mylan Stibbe advises global pharmaceutical company Mylan on the merger control aspects of its USD 7.2 billion acquisition of Swedish drugmaker Meda. Stibbe advises Aedifica Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on reaching agreement to acquire two new senior housing sites in Lochem and Rotterdam. Stibbe advises Aedifica Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on the acquisition of a new senior housing site in Arnhem. This is the second investment of Aedifica in The Netherlands. Aedifica has developed a portfolio of health Pagination Previous page Page 2 Current page 3 Page 4 Page 5 Next page
Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations.
Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.
Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.
Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin.
Stibbe represents the bankruptcy trustees of Amsterdam hospital MC Slotervaart in dispute with the City of Amsterdam Stibbe represented the bankruptcy trustees of the Amsterdam hospital MC Slotervaart in proceedings against the City of Amsterdam, centred on the City’s demand that the bankruptcy trustees investigate whether there were any irregularities prior to the ban
Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.
Stibbe advises Aedifica Stibbe advised Aedifica on the acquisition of a healthcare residence for the elderly in Franeker (Friesland).
Dutch national police service liable for unlawful granting of firearms permit In a recent decision (ECLI:NL:HR:2019:1409), the Supreme Court has decided that the Dutch national police force is liable for damage suffered by victims of a shooting which took place in a shopping centre in 2011; an event that shocked the Netherlands.
Stibbe advises Wright Medical Group Stibbe is advising Wright Medical Group on the offer from Stryker to acquire Wright Medical Group.
Stibbe advises Aedifica Stibbe advised Aedifica on its secondary share listing on Euronext Amsterdam. Trading started on 7 November 2019.
Stibbe advises Aedifica Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Lelystad and the acquisition and lease of a recently completed care residence in Zwolle.
Breaking news from the CJEU: no SPCs for new therapeutic applications On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products.
Stibbe advises leading pharmaceutical company Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients.
Stibbe advises Canon Advising Canon in connection with their dispute with the State of the Netherlands on the procurement of framework contracts. Case won up to and including the Supreme Court.
Stibbe advises Mylan Stibbe advises global pharmaceutical company Mylan on the merger control aspects of its USD 7.2 billion acquisition of Swedish drugmaker Meda.
Stibbe advises Aedifica Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on reaching agreement to acquire two new senior housing sites in Lochem and Rotterdam.
Stibbe advises Aedifica Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on the acquisition of a new senior housing site in Arnhem. This is the second investment of Aedifica in The Netherlands. Aedifica has developed a portfolio of health